Target intelligence / Profile preview

Pre-mRNA processing factor 19 (PRPF19)

Target
PRPF19
Molecular classification
Enzyme (E3 ubiquitin ligase), Spliceosomal protein, Component of the PRP19 complex (“Nineteen complex” or NTC), DNA repair factor
01

Overview

Pre-mRNA processing factor 19 (PRPF19) is a highly conserved E3 ubiquitin ligase that serves as a central scaffold and enzymatic component of the spliceosome, required for pre-mRNA splicing and the DNA damage response. As a core constituent of the PRP19 complex/Nineteen complex (NTC), PRPF19 is essential for spliceosome assembly, catalysis, and remodeling; it mediates Lys-63–linked polyubiquitination of spliceosomal proteins, facilitating snRNP complex transitions. PRPF19 is also directly implicated in DNA double-strand break repair, where it targets RPA1 and RPA2 for ubiquitination, activating ATR-dependent signaling. It has further roles in transcription-coupled repair, protein degradation, cell proliferation, apoptosis suppression, and potentially neural development and lipid droplet biogenesis. PRPF19’s dysfunction or aberrant regulation is linked to cancer and other diseases, making it a subject of therapeutic research, yet targeting it poses significant challenges due to its fundamental roles in cell function

Other names
PRP19PSO4hPrp19Nuclear matrix protein 42 (NMP42)
02

Mechanism of action

For investigational approaches: inhibition or modulation of spliceosome assembly or ubiquitin ligase activity to impact RNA processing, DNA repair, and apoptosis, particularly in oncology

03

Biological functions

Pre-mRNA splicing (spliceosome assembly, activity, and remodeling)Ubiquitination (Lys-63- and Lys-48-linked polyubiquitination)DNA damage response and repair (DSB repair, ATR activation, interaction with RPA)Transcription-coupled repairRegulation of mRNA maturationRegulation of protein degradation (through ubiquitin-proteasome system)Cell proliferationApoptosis modulationPossibly lipid droplet biogenesis and neural differentiation
04

Disease associations

Cancer (oncogenesis, especially via repression of apoptosis)Spondylometaphyseal dysplasia with corneal dystrophySchwannomatosis 1Neurodegenerative diseases (implicated via mutations in spliceosome components)DNA repair–related pathologies
05

Safety considerations

Potential for broad cellular toxicity due to PRPF19’s essential role in fundamental processes such as pre-mRNA splicing and DNA repair, making selectivity, dosing, and therapeutic window key concernsRisk of impaired DNA repair and genomic instability if inhibitedUnintended effects on cell viability and neural differentiation if targeted systemically
06

Interacting drugs

No approved drugs are known to bind directly to PRPF19 as a primary pharmacological target as of now. However, it is under investigation as a novel target in cancer therapy, with interest in modulating spliceosome function or its ubiquitin ligase activity for therapeutic benefit
07

Biomarkers

PRPF19 expression or mutation status is being investigated as a potential biomarker in cancers due to its role in cell proliferation, apoptosis, and DNA repair pathways

Beyond the preview

Go deeper on Pre-mRNA processing factor 19 (PRPF19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-mRNA processing factor 19 (PRPF19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call